Oscar Health (MIL:1OSCR) ROCE %: % (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1OSCR Oscar Health Inc MIL:1OSCR
51 GF Score
Price €26.98
GF Value €18.01
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Oscar Health ROCE %?

Oscar Health MIL:1OSCR -0.30% 51 ROCE % is % as of Mar. 2026. GuruFocus rates MIL:1OSCR with a GF Score™ of 51/100 and a GF Value™ of €18.01 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

MIL:1OSCR
51GF Score
Oscar Health Inc MIL:1OSCR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
Oscar Health (MIL:1OSCR) has a ROCE % of % as of Mar. 2026.
Is Oscar Health's ROCE % too high?
Oscar Health's current ROCE % is %. Overall, Oscar Health has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's ROCE % compare to MOH and ALHC?
Oscar Health's ROCE % of % can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 9.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Plans company?
The median ROCE % among Healthcare Plans companies is 9.38, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oscar Health's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (MIL:1OSCR) is currently considered Significantly Overvalued. The stock's GF Value™ is €18.01, compared to a current price of €26.98 — trading 49.8% above its estimated fair value. The current ROCE % is %. Oscar Health's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Oscar Health (MIL:1OSCR), the current ROCE % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oscar Health (MIL:1OSCR) Overvalued in 2026?

Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued. The current stock price of €26.98 is trading 49.8% above its estimated GF Value™ of €18.01. GuruFocus considers Oscar Health to be Significantly Overvalued.

Key valuation signals for MIL:1OSCR:

  • ROCE %: %
  • GF Value™: €18.01 vs. price of €26.98 (49.8% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the MIL:1OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oscar Health Business Description

Address 75 Varick Street, 5th Floor, New York, NY, USA, 10013
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
51GF Score

Get the complete analysis for MIL:1OSCR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.98
Price
€18.01
GF Value